Italy probes "orphan drug" excessive pricing

Emily Craig

16 October 2019

Italy probes "orphan drug" excessive pricing

Credit: iStock/Fahroni

Italy’s Competition Authority has launched a preliminary investigation into a pharmaceutical group for abusing its dominant position by charging excessive prices.